Medication Assisted
Module References and Resources: Medication Assisted Treatment for Opioid, Alcohol, and Smoking
- 2015. Results from the 2014 National Survey on Drug Use and Health: Detailed tables. Center for Behavioral Health Statistics and Quality.Rockville, MD: Substance Abuse and Mental Health Services Administration.
- 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019; 67:674.
- A Day in the Life of Older Adults: Substance Use Facts. Wu, LT et al. Journal of Aging and Health, 23(3), 481–504. Substance Abuse and Mental Health Services Administration. (2018)
- Acamprosate [prescribing information]. Morgantown, WV: Mylan Pharmaceuticals Inc; September 2015.
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Mattick RP, Breen C, Kimber J, Davoli M. Cochrane Database Syst Rev 2014; :CD002207.
- Centers for Disease Control and Prevention. Smoking & Tobacco Use
- Chantix (varenicline) [prescribing information]. New York, NY: Pfizer Labs; February 2019.
- Cigarette smoking among the elderly: disease consequences and the benefits of cessation. Burns DM. Am J Health Promot 2000; 14:357.
- Clinical pharmacology of buprenorphine: ceiling effects at high doses. Walsh SL, Preston KL, Stitzer ML, et al. Clin Pharmacol Ther 1994; 55:569.
- Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.
- Effect of general practitioners' advice against smoking. Russell MA, Wilson C, Taylor C, Baker CD. Br Med J 1979; 2:231.
- Exposure to opioid maintenance treatment reduces long-term mortality. Gibson A, Degenhardt L, Mattick RP, et al. Addiction 2008; 103:462.
- Helping patients who drink too much: A clinician’s guide. National Institute on Alcohol Abuse and Alcoholism. NIH Publication no. 05-3769, Bethesda, MD 2005. Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA 2014; 311:1889.
- Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al. J Anal Toxicol 1996; 20:369.
- Illicit and nonmedical drug use among older adults: A review. Journal of Aging and Health, 23(3), 481–504. Wu, L. T., & Blazer, D. G. (2011).
- Methadone Hydrochloride oral solution [prescribing information]. Eatontown, NJ: West-Ward Pharmaceuticals; August 2018.
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Mattick RP, Breen C, Kimber J, Davoli M. Cochrane Database Syst Rev 2009; :CD002209.
- National Institute on Alcohol Abuse and Alcoholism
- Nicorette Mini (nicotine) lozenge [prescribing information]. Moon Township, PA: GlaxoSmithKline Consumer Healthcare; 2015.
- Nicotrol (nicotine) inhalation system [prescribing information]. New York, NY: Pfizer; September 2019.
- Opiate withdrawal. Addiction Farrell M. 1994; 89:1471.
- Opioid antagonists for alcohol dependence. Rösner S, Hackl-Herrwerth A, Leucht S, et al. Cochrane Database Syst Rev 2010; :CD001867.
- Opioid-Related Inpatient Stays and Emergency Department Visits Among Patients Aged 65 Years and Older, 2010 and 2015: Statistical Brief #244. Weiss AJ, et al. Rockville (MD) 2018.
- Opioids in Medicare Part D - Office of Inspector General. U.S. Department of Health & Human Services, HHS OIG Data Brief. July 2017.
- Opioid Use Disorders. Sharma, B, et al. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3): 473–487.
- Oral naltrexone maintenance treatment for opioid dependence. Minozzi S, Amato L, Vecchi S, et al. Cochrane Database Syst Rev 2011; :CD001333.
- Quality indicators for screening and prevention in vulnerable elders. Gnanadesigan N, Fung CH. J Am Geriatr Soc 2007; 55 Suppl 2:S417.
- Quitting Smoking Among Adults—United States, 2000–2015. Morbidity and Mortality Weekly Report.Babb S, Malarcher A, Schauer G, Asman K, Jamal A. 2017;65(52):1457-64
- Relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: An overview. Rehm J, et al. Addiction. 98(9):1209- 1228, 2003.
- Revia (naltrexone) [prescribing information].
- SAMHSA
- SAMHSA-certified opioid treatment program.
- SAMHSA. Federal Guidelines for Opioid Treatment Programs, HHS Publication No
- SAMHSA - Use of Medication-Assisted Treatment for Opioid Use Disorder
- Smoking and all-cause mortality in older people: systematic review and meta-analysis. Gellert C, Schöttker B, Brenner H. Arch Intern Med 2012; 172:837.
- Substance Abuse and Mental Health Services Administration. (2018). Results from the 2017 National Survey on Drug Use and Health: Detailed Tables.
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. Reus, V.I., et al. American Journal of Psychiatry, 175(1), 86-90, 2018.
- The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Walsh SL, Eissenberg T. Drug Alcohol Depend. 2003;70(suppl 2):S13-S27
- The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. U.S. Department of Health and Human Services. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 .
- The neurobiology of opioid dependence: implications for treatment. Kosten TR, et al. Sci Pract Perspect. 2002;1(1):13–20.
- The prevalence of harmful and hazardous alcohol consumption in older U.S. adults: data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES). Wilson SR, Knowles SB, Huang Q, Fink A. J Gen Intern Med 2014; 29:312.
- Vivitrol (naltrexone) [prescribing information]. Waltham, MA: Alkermes, Inc; September 2019.
- Zyban (bupropion hydrochloride) [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; July 2019